Abstract
The goal of this series of books on cancer markers is to summarize and illustrate the state of the art in the use of markers for diagnosis, prognosis, and monitoring the effect of therapy on malignant tumors (1–5). The purpose of this volume in the series is to present the current status of chromosomal markers of cancer, not only for their potential and realized clinical utility in diagnosis, prognosis, and disease monitoring, but also for their contributions to understanding mechanisms of tumor development and progression. These mechanisms have been identified largely by localization of relevant oncogenes and tumor suppressor genes, and by recognition of new gene constructs (and their protein products and cellular functions) that result from translocation in the course of carcinogenesis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sell S (ed.): Cancer Markers: Diagnostic and Developmental Significance. Clifton, NJ: Humana, 1980.
Sell S, Wahren B (eds.): Human Cancer Markers. Clifton, NJ: Humana, 1982.
Sell S Reisfeld R (eds.): Monoclonal Antibodies in Cancer. Clifton, NJ: Humana, 1985.
Sell S (ed.): Serological Cancer Markers. Totowa, NJ: Humana, 1992.
Garrett CT and Sell S (eds.): Cellular Cancer Markers. Totowa, NJ: Humana, 1995.
Boveri T: Auf Fragender Entstehung maligner Tumoren, Fisher, Jena (English translation: Boveri, M: The Origin of Malignant Tumors, Baltimore, MD: Williams and Wilkins, 1929.)
Muller HJ: Measurement of gene mutation rate in Drosophila, its high variability, and its dependence upon temperature. Genetics 13:279–357, 1928.
Furth J, Furth OB: Neoplastic diseases produced in mice by general irradiation with x-rays. Am J Cancer 28:54–65, 1936.
National Research Council, Advisory Committee on the Biological Effects of Ionizing Radiations. The Effects on Populations of Exposure to Low Levels of Ionizing Radiation. Washington, DC: National Academy of Sciences, chapter V, pp. 135–471, 1980.
Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960.
Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290–293, 1973.
Mitelman F: Catalog of Chromosome Aberrations in Cancer, 1st, 2nd, and 3rd editions, New York: Liss, 1983, 1985, 1988;
Mitelman F: Catalog of Chromosome Aberrations in Cancer 4th and 5th editions, New York, Wiley-Liss, 1991, 1994.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Humana Press Inc.
About this chapter
Cite this chapter
Wolman, S.R., Sell, S., Wolman, E. (1997). An Introduction to Cancer Markers and Cytogenetics. In: Wolman, S.R., Sell, S. (eds) Human Cytogenetic Cancer Markers. Contemporary Biomedicine, vol 13. Humana Press. https://doi.org/10.1007/978-1-4612-3952-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3952-9_1
Publisher Name: Humana Press
Print ISBN: 978-1-4612-8437-6
Online ISBN: 978-1-4612-3952-9
eBook Packages: Springer Book Archive